Interferon-α therapy in HCV hepatitis: HLA phenotype and cirrhosis are independent predictors of clinical outcome

Human Immunology

Volumn 59, Issue 4, 1998, Pages 239-242

  Almarri, Ajayeb ^a,b   El Dwick, Nazeh ^a   Al Kabi, Saad ^a   Sleem, Khalid ^a   Rashed, Awad ^a   Ritter, Mary A ^b   Batchelor, J Richard ^b  

^a HAMAD MEDICAL CORPORATION   (Qatar)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; HLA ANTIGEN CLASS 2; HLA DR2 ANTIGEN; LIVER ENZYME;

ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C; HEPATITIS C VIRUS; HLA SYSTEM; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

ADULT; HEPATITIS C, CHRONIC; HLA-DR2 ANTIGEN; HUMANS; IMMUNOPHENOTYPING; INTERFERON-ALPHA; LIVER CIRRHOSIS; MULTIVARIATE ANALYSIS; PROGNOSIS; TREATMENT OUTCOME;

EID: 0031902367     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(98)00010-X     Document Type: Article

References (29)

1. Van der Poel C, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet. 344:1994;1475.
2. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A. Hepatitis interventional therapy group treatment of chronic hepatitis C with recombinant interferon alfa.A multicenter randomized, controlled trial . N Engl J Med. 321:1989;1501.
3. Tine F, Magrin S, Craxi A, Pagliaro L. Interferon for non-A, non-B chronic hepatitis A meta-analysis of randomised clinical trials . J Hepatol. 13:1991;192.
4. Chayama K, Saitoh S, Arase Y, Ikeda K, Matsumoto T, Sakai Y, Kobayashi M, Unakami M, Morinaga T, Kumada H. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C. Hepatology. 13:1991;1040.
5. Sherlock S. Viral hepatitis. Curr Opin Gastro. 8:1992;365.
6. Marcellin P, Benhamou JP. Treatment of chronic hepatitis C with interferon alpha. Gastroenterol Clin Biol. 15:1991;613.
7. Hoofnagle JH, Di Bisceglie AM, Shindo M. Antiviral therapy of hepatitis C present and future. J Hepatol. 17:(Suppl 3):1993;S130.
8. Conjeevaram HS, Di Bisceglie AM. Management of chronic viral hepatitis in children. J Pediatr Gastroenterol Nutr. 20:1995;365X.
9. Davis GL, Lim H. Current status of interferon therapy for hepatitis C A hepatologist's view . Infectious Agents Dis. 2:1993;150.
10. Yoshioka K, Kukumu S, Hayashi H, Shinagawa T, Wakita T, Ishikawa T, Itoh Y, Takayanagi M. Anti-hepatitis C antibodies in patients with chronic non-A, non-B hepatitis relation to disease progression and effect of interferon alpha . Am J Gastroenterol. 86:1991;1495.
11. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet. 339:1992;1543.
12. Tsubota A, Chayama K, Arase Y, Koida I, Saitoh S, Ideda K, Iwasaki S, Matsumoto T, Kobayashi M, Kumada II. factors useful in predicting the response of interferon therapy in chronic hepatitis C. J Gastroenterol Hepatol. 8:1993;535X.
13. Hino K, Sainokami S, Shimoda K, Iino S, Wang Y, Okamoto H, Miyakawa Y, Mayumi M. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C. J Med Virol. 42:1994;299.
14. Takada N, Takase S, Enomoto N, Takada A, Date T. Clinical backgrounds of the patients having different types of hepatitis C virus genomes. J Hepatol. 14:1992;35.
15. Yamada G, Takahashi M, Miyamoto R, Tsuji T, Yoshizawa H, Okamoto H. Prediction of interferon effect in chronic hepatitis C by both quantification and genotyping of HCV-RNA. Dig Dis Sci. 39:1994;441.
16. Chemello L, Alberti A, Rose K, Simmonds P. Hepatitis C serotype and response to interferon therapy. N Engl J Med. 330:1994;143.
17. Hagiwara H, Hayashi N, Fusamoto H, Kamada T. Quantitative analysis of heptatis C virus RNA relationship between the replicative level and the various stages of the carrier states or the response to interferon therapy . Gastroenterol Jpn. 28:(Suppl 5):1993;48.
18. Kobayashi Y, Watanabe S, Konishi M, Yokoi M, Kakehashi R, Kaito M, Kondo M, Hayashi Y, Jomori T, Suzuki S. Quantitiation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with intereron-beta. Hepatology. 18:1993;1319.
19. Toyoda H, Nakano S, Takeda I, Kumada T, Sugiyama K, Osada T, Kiriyama S, Suga T, Ohki H, Ito O, Ebata M, Takahashi M. Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol. 89:1994;1453.
20. Battezzati PM, Podda M, Bruno S, Zuin M, Crosignani A, Camisasca M, Chiesa A, Petroni ML, Russo A, Gallotti P. Factors predicting early response to treatment with recombinant interferon alpha-2α in chronic non-A, non-B hepatitis Preliminary report of a long term trial . Ital J Gastroenterol. 24:1992;481.
21. Saeed AA, Al Admawi AM, Al Rasheed A, Fairclough D, Bacchus R, Ring C, Garson J. Hepatitis C virus infection in Egyptian volunteer blood donors in Riyadh. Lancet. 338:1991;459.
22. Bukh J, Purcell RH, Miller RH. Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay. Proc Natl Acad Sci USA. 89:1992;187.
23. Al Marri A, Batchelor JR. HLA and hepatitis B infection. Lancet. 334:1994;1194.
24. Davis GL. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol. 21:1994;1.
25. Giacchino R, Timitilli A, Cristina F, Giambartolomei G, Leonardi D, Caocci F, Cirillo C. Repeated course of interferon treatment in chronic hepatitis B in childhood. Arch Virol Suppl. 4:1992;273.
26. Par A, Paal M, Gogl A, Gervain J, Szekeres J, Sipos J, Bero T, Hutter E, Berencsi G, Kadas I. Clinical immunological features and interferon therapy in chronic hepatitis C. Orv Hetil. 136:1995;9.
27. McOmish F, Yap PL, Dow BC, Follett EA, Seed C, Keller AJ, Cobain TJ, Krusius T, Kolho E, Naukkarinen R, Lin C, Lai C, Leong S, Medgyesi GA, Hijjas M, Kiyokawa H, Fukada K, Cuypers T, Saeed AA, Al Rasheed AM, Lin M, Simmonds P. Geographical distribution of hepatitis C genotypes in blood donors an international collaborative survey . J Clin Microbiol. 32:1994;884.
28. Simmonds P, McOmish F, Yap PL, Chan SW, Lin CK, Dusheiko G, Saeed AA, Holmes EC. Sequence variability in the 5′ non-coding region of hepatitis C virus identification of a new virus type and restrictions on sequence diversity . J Gen Virol. 74:1993;661.
29. Congia M, Clemente MG, Dessi C, Cucca F, Mazzoleni AP, Frau F, Lampis R, Cao A, Lai ME, De Virgilis S. HLA class II genes in chronic hepatitis C virus-infection and associated immunological disorders. Hepatol. 24:1996;1338.